James M. Gold - Publications

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Neuropsychology, Schizophrenia

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lopez-Garcia P, Lesh TA, Salo T, Barch DM, MacDonald AW, Gold JM, Ragland JD, Strauss M, Silverstein SM, Carter CS. The neural circuitry supporting goal maintenance during cognitive control: a comparison of expectancy AX-CPT and dot probe expectancy paradigms. Cognitive, Affective & Behavioral Neuroscience. PMID 26494483 DOI: 10.3758/s13415-015-0384-1  1
2015 Erickson MA, Ruffle A, Gold JM. A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression. Biological Psychiatry. PMID 26444073 DOI: 10.1016/j.biopsych.2015.08.025  0.88
2015 Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, ... ... Gold JM, et al. Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. Schizophrenia Bulletin. PMID 26362273 DOI: 10.1093/schbul/sbv111  0.88
2015 Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates. Schizophrenia Bulletin. PMID 26209546 DOI: 10.1093/schbul/sbv090  1
2015 Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms. Schizophrenia Bulletin. PMID 26142081 DOI: 10.1093/schbul/sbv089  1
2015 Green MF, Horan WP, Barch DM, Gold JM. Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophrenia Bulletin. PMID 26089350 DOI: 10.1093/schbul/sbv071  1
2015 Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, Richardson CM, Fischer BA, Keller WR, Koola MM, Feldman SM, Russ JC, et al. Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. Journal of Clinical Psychopharmacology. 35: 374-81. PMID 26082974 DOI: 10.1097/JCP.0000000000000345  1
2015 Palatnik A, Mele L, Landon MB, Reddy UM, Ramin SM, Carpenter MW, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Saade GR, Caritis SN, Sorokin Y, et al. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. American Journal of Obstetrics and Gynecology. 213: 560.e1-8. PMID 26071920 DOI: 10.1016/j.ajog.2015.06.022  1
2015 Gold JM, Waltz JA, Frank MJ. Effort Cost Computation in Schizophrenia: A Commentary on the Recent Literature. Biological Psychiatry. PMID 26049208 DOI: 10.1016/j.biopsych.2015.05.005  1
2015 Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/j.schres.2015.05.018  1
2015 Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald Iii AW, Daniel Ragland J, Silverstein SM, Godwin D, Barch DM. Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia. Neuropsychologia. 73: 82-93. PMID 25979608 DOI: 10.1016/j.neuropsychologia.2015.05.006  1
2015 Brown EC, Hack SM, Gold JM, Carpenter WT, Fischer BA, Prentice KP, Waltz JA. Integrating frequency and magnitude information in decision-making in schizophrenia: An account of patient performance on the Iowa Gambling Task. Journal of Psychiatric Research. 66: 16-23. PMID 25959618 DOI: 10.1016/j.jpsychires.2015.04.007  1
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1-10. PMID 25916421 DOI: 10.1017/S0033291715000641  1
2015 Waltz JA, Brown JK, Gold JM, Ross TJ, Salmeron BJ, Stein EA. Probing the Dynamic Updating of Value in Schizophrenia Using a Sensory-Specific Satiety Paradigm. Schizophrenia Bulletin. PMID 25834028 DOI: 10.1093/schbul/sbv034  1
2015 Strauss GP, Keller WR, Koenig JI, Gold JM, Frost KH, Buchanan RW. Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. Schizophrenia Research. 162: 47-51. PMID 25673435 DOI: 10.1016/j.schres.2015.01.034  1
2015 Strauss GP, Keller WR, Koenig JI, Sullivan SK, Gold JM, Buchanan RW. Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia. Schizophrenia Research. 162: 52-6. PMID 25620121 DOI: 10.1016/j.schres.2015.01.022  1
2015 Morra LF, Gold JM, Sullivan SK, Strauss GP. Predictors of neuropsychological effort test performance in schizophrenia. Schizophrenia Research. 162: 205-10. PMID 25583248 DOI: 10.1016/j.schres.2014.12.033  1
2015 Strauss GP, Keller WR, Koenig JI, Gold JM, Ossenfort KL, Buchanan RW. Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophrenia Research. 162: 57-61. PMID 25583247 DOI: 10.1016/j.schres.2014.12.023  1
2015 Strauss GP, Kappenman ES, Culbreth AJ, Catalano LT, Ossenfort KL, Lee BG, Gold JM. Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli. Journal of Abnormal Psychology. 124: 288-301. PMID 25486078 DOI: 10.1037/abn0000017  1
2015 Buchanan RW, Weiner E, Kelly DL, Gold JM, Keller WR, Waltz JA, McMahon RP, Gorelick DA. Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 41: 900-8. PMID 25368372 DOI: 10.1093/schbul/sbu151  1
2015 Erickson MA, Hahn B, Leonard CJ, Robinson B, Gray B, Luck SJ, Gold J. Impaired working memory capacity is not caused by failures of selective attention in schizophrenia. Schizophrenia Bulletin. 41: 366-73. PMID 25031223 DOI: 10.1093/schbul/sbu101  1
2015 Strauss GP, Morra LF, Sullivan SK, Gold JM. The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia. Neuropsychology. 29: 282-91. PMID 25000322 DOI: 10.1037/neu0000113  1
2015 Gold JM, Kool W, Botvinick MM, Hubzin L, August S, Waltz JA. Cognitive effort avoidance and detection in people with schizophrenia. Cognitive, Affective & Behavioral Neuroscience. 15: 145-54. PMID 24957405 DOI: 10.3758/s13415-014-0308-5  1
2015 Silverstein SM, Harms MP, Carter CS, Gold JM, Keane BP, MacDonald A, Daniel Ragland J, Barch DM. Cortical contributions to impaired contour integration in schizophrenia Neuropsychologia. 75: 469-480. DOI: 10.1016/j.neuropsychologia.2015.07.003  1
2015 Ragland JD, Ranganath C, Harms MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS. Functional and neuroanatomic specificity of episodic memory dysfunction in schizophrenia: A functional magnetic resonance imaging study of the relational and item-specific encoding task Jama Psychiatry. 72: 909-916. DOI: 10.1001/jamapsychiatry.2015.0276  1
2014 Wonodi I, McMahon RP, Krishna N, Mitchell BD, Liu J, Glassman M, Hong LE, Gold JM. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia. Schizophrenia Research. 160: 80-7. PMID 25464917 DOI: 10.1016/j.schres.2014.10.026  1
2014 Collins AG, Brown JK, Gold JM, Waltz JA, Frank MJ. Working memory contributions to reinforcement learning impairments in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 13747-56. PMID 25297101 DOI: 10.1523/JNEUROSCI.0989-14.2014  1
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/j.schres.2014.07.032  1
2014 Luck SJ, McClenon C, Beck VM, Hollingworth A, Leonard CJ, Hahn B, Robinson BM, Gold JM. Hyperfocusing in schizophrenia: Evidence from interactions between working memory and eye movements. Journal of Abnormal Psychology. 123: 783-95. PMID 25089655 DOI: 10.1037/abn0000003  1
2014 Kiwanuka JN, Strauss GP, McMahon RP, Gold JM. Psychological predictors of functional outcome in people with schizophrenia. Schizophrenia Research. 157: 299-304. PMID 24878429 DOI: 10.1016/j.schres.2014.04.030  1
2014 Gray BE, Hahn B, Robinson B, Harvey A, Leonard CJ, Luck SJ, Gold JM. Relationships between divided attention and working memory impairment in people with schizophrenia. Schizophrenia Bulletin. 40: 1462-71. PMID 24748559 DOI: 10.1093/schbul/sbu015  1
2014 Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ. Enhanced distraction by magnocellular salience signals in schizophrenia. Neuropsychologia. 56: 359-66. PMID 24561035 DOI: 10.1016/j.neuropsychologia.2014.02.011  1
2014 Doll BB, Waltz JA, Cockburn J, Brown JK, Frank MJ, Gold JM. Reduced susceptibility to confirmation bias in schizophrenia. Cognitive, Affective & Behavioral Neuroscience. 14: 715-28. PMID 24481852 DOI: 10.3758/s13415-014-0250-6  1
2014 Strauss GP, Waltz JA, Gold JM. A review of reward processing and motivational impairment in schizophrenia. Schizophrenia Bulletin. 40: S107-16. PMID 24375459 DOI: 10.1093/schbul/sbt197  1
2014 Sheffield JM, Gold JM, Strauss ME, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Barch DM. Common and specific cognitive deficits in schizophrenia: relationships to function. Cognitive, Affective & Behavioral Neuroscience. 14: 161-74. PMID 24037621 DOI: 10.3758/s13415-013-0211-5  1
2014 Strauss ME, McLouth CJ, Barch DM, Carter CS, Gold JM, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Keane BP, Silverstein SM. Temporal stability and moderating effects of age and sex on CNTRaCS task performance. Schizophrenia Bulletin. 40: 835-44. PMID 23817024 DOI: 10.1093/schbul/sbt089  1
2013 Leonard CJ, Robinson BM, Kaiser ST, Hahn B, McClenon C, Harvey AN, Luck SJ, Gold JM. Testing sensory and cognitive explanations of the antisaccade deficit in schizophrenia. Journal of Abnormal Psychology. 122: 1111-20. PMID 24364614 DOI: 10.1037/a0034956  1
2013 Kline E, Gold JM, Schiffman J. Response to 'A systematic review and meta-regression analysis of aggression during first episode of psychosis'. Acta Psychiatrica Scandinavica. 128: 492. PMID 23952522 DOI: 10.1111/acps.12181  1
2013 Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/appi.ajp.2013.12101298  1
2013 Brown JK, Waltz JA, Strauss GP, McMahon RP, Frank MJ, Gold JM. Hypothetical decision making in schizophrenia: the role of expected value computation and "irrational" biases. Psychiatry Research. 209: 142-9. PMID 23664664 DOI: 10.1016/j.psychres.2013.02.034  1
2013 Gray BE, McMahon RP, Gold JM. General intellectual ability does not explain the general deficit in schizophrenia. Schizophrenia Research. 147: 315-9. PMID 23664590 DOI: 10.1016/j.schres.2013.04.016  1
2013 Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry. 74: 436-43. PMID 23660272 DOI: 10.1016/j.biopsych.2013.03.017  1
2013 Johnson MK, McMahon RP, Robinson BM, Harvey AN, Hahn B, Leonard CJ, Luck SJ, Gold JM. The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia. Neuropsychology. 27: 220-9. PMID 23527650 DOI: 10.1037/a0032060  1
2013 Owoso A, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM, Strauss ME, Barch DM. Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different. Psychological Medicine. 43: 2535-45. PMID 23522057 DOI: 10.1017/S0033291713000536  1
2013 Waltz JA, Kasanova Z, Ross TJ, Salmeron BJ, McMahon RP, Gold JM, Stein EA. The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia. Plos One. 8: e57257. PMID 23468948 DOI: 10.1371/journal.pone.0057257  1
2013 Strauss GP, Catalano LT, Llerena K, Gold JM. The processing of emotional stimuli during periods of limited attentional resources in schizophrenia. Journal of Abnormal Psychology. 122: 492-505. PMID 23421529 DOI: 10.1037/a0031212  1
2013 Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biological Psychiatry. 74: 130-6. PMID 23394903 DOI: 10.1016/j.biopsych.2012.12.022  1
2013 Strauss GP, Kappenman ES, Culbreth AJ, Catalano LT, Lee BG, Gold JM. Emotion regulation abnormalities in schizophrenia: cognitive change strategies fail to decrease the neural response to unpleasant stimuli. Schizophrenia Bulletin. 39: 872-83. PMID 23314192 DOI: 10.1093/schbul/sbs186  1
2013 Gold JM, Dickinson D. "Generalized cognitive deficit" in schizophrenia: overused or underappreciated? Schizophrenia Bulletin. 39: 263-5. PMID 23211397 DOI: 10.1093/schbul/sbs143  1
2013 Hahn B, Gold JM, Buchanan RW. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia. Neuropharmacology. 64: 185-90. PMID 22705396 DOI: 10.1016/j.neuropharm.2012.05.050  1
2013 Leonard CJ, Kaiser ST, Robinson BM, Kappenman ES, Hahn B, Gold JM, Luck SJ. Toward the neural mechanisms of reduced working memory capacity in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 23: 1582-92. PMID 22661407 DOI: 10.1093/cercor/bhs148  1
2012 Strauss GP, Keller WR, Buchanan RW, Gold JM, Fischer BA, McMahon RP, Catalano LT, Culbreth AJ, Carpenter WT, Kirkpatrick B. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. Schizophrenia Research. 142: 88-92. PMID 23127378 DOI: 10.1016/j.schres.2012.10.012  1
2012 Knowles EE, Weiser M, David AS, Dickinson D, Glahn D, Gold J, Davidson M, Reichenberg A. Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophrenia Research. 142: 129-36. PMID 23084540 DOI: 10.1016/j.schres.2012.08.020  1
2012 Strauss GP, Hong LE, Gold JM, Buchanan RW, McMahon RP, Keller WR, Fischer BA, Catalano LT, Culbreth AJ, Carpenter WT, Kirkpatrick B. Factor structure of the Brief Negative Symptom Scale. Schizophrenia Research. 142: 96-8. PMID 23062750 DOI: 10.1016/j.schres.2012.09.007  1
2012 Strauss GP, Lee BG, Waltz JA, Robinson BM, Brown JK, Gold JM. Cognition-emotion interactions are modulated by working memory capacity in individuals with schizophrenia. Schizophrenia Research. 141: 257-61. PMID 22968207 DOI: 10.1016/j.schres.2012.08.010  1
2012 Keane BP, Silverstein SM, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald AW, Ragland JD, Strauss ME. The spatial range of contour integration deficits in schizophrenia. Experimental Brain Research. 220: 251-9. PMID 22710617 DOI: 10.1007/s00221-012-3134-4  1
2012 Hahn B, Robinson BM, Kaiser ST, Matveeva TM, Harvey AN, Luck SJ, Gold JM. Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time. Journal of Abnormal Psychology. 121: 641-8. PMID 22686867 DOI: 10.1037/a0028492  1
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/j.schres.2012.03.025  1
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/j.schres.2012.03.026  1
2012 Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. The American Journal of Psychiatry. 169: 364-73. PMID 22407079 DOI: 10.1176/appi.ajp.2011.11030447  1
2012 Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AG, Frank MJ. Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Archives of General Psychiatry. 69: 129-38. PMID 22310503 DOI: 10.1001/archgenpsychiatry.2011.1269  1
2012 Henderson D, Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, Strauss ME, MacDonald AW. Optimization of a goal maintenance task for use in clinical applications. Schizophrenia Bulletin. 38: 104-13. PMID 22199092 DOI: 10.1093/schbul/sbr172  1
2012 Gold J. Cognitive neuroscience test reliability and clinical applications for schizophrenia. Schizophrenia Bulletin. 38: 103. PMID 22199091 DOI: 10.1093/schbul/sbr173  1
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/j.schres.2011.11.001  1
2012 Boggs DL, Kelly DL, McMahon RP, Gold JM, Gorelick DA, Linthicum J, Conley RR, Liu F, Waltz J, Huestis MA, Buchanan RW. Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophrenia Research. 134: 207-10. PMID 22137462 DOI: 10.1016/j.schres.2011.11.009  1
2012 Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW, Silverstein SM, Strauss ME, Yonelinas AP, Carter CS. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics. Schizophrenia Bulletin. 38: 114-24. PMID 22124089 DOI: 10.1093/schbul/sbr146  1
2012 Barch DM, Carter CS, Dakin SC, Gold J, Luck SJ, Macdonald A, Ragland JD, Silverstein S, Strauss ME. The clinical translation of a measure of gain control: the contrast-contrast effect task. Schizophrenia Bulletin. 38: 135-43. PMID 22101963 DOI: 10.1093/schbul/sbr154  1
2012 Gold JM, Barch DM, Carter CS, Dakin S, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Kovacs I, Silverstein SM, Strauss M. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophrenia Bulletin. 38: 144-52. PMID 22101961 DOI: 10.1093/schbul/sbr142  1
2012 August SM, Kiwanuka JN, McMahon RP, Gold JM. The MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlates. Schizophrenia Research. 134: 76-82. PMID 22093182 DOI: 10.1016/j.schres.2011.10.015  1
2012 Kappenman ES, Kaiser ST, Robinson BM, Morris SE, Hahn B, Beck VM, Leonard CJ, Gold JM, Luck SJ. Response activation impairments in schizophrenia: evidence from the lateralized readiness potential. Psychophysiology. 49: 73-84. PMID 22091661 DOI: 10.1111/j.1469-8986.2011.01288.x  1
2012 Hahn B, Hollingworth A, Robinson BM, Kaiser ST, Leonard CJ, Beck VM, Kappenman ES, Luck SJ, Gold JM. Control of working memory content in schizophrenia. Schizophrenia Research. 134: 70-5. PMID 22079944 DOI: 10.1016/j.schres.2011.10.008  1
2012 Silverstein SM, Keane BP, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald A, Ragland JD, Strauss ME. Optimization and validation of a visual integration test for schizophrenia research. Schizophrenia Bulletin. 38: 125-34. PMID 22021658 DOI: 10.1093/schbul/sbr141  1
2012 Hahn B, Robinson BM, Harvey AN, Kaiser ST, Leonard CJ, Luck SJ, Gold JM. Visuospatial attention in schizophrenia: deficits in broad monitoring. Journal of Abnormal Psychology. 121: 119-28. PMID 21604825 DOI: 10.1037/a0023938  1
2012 Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. The Journal of Clinical Psychiatry. 73: 95-102. PMID 21535998 DOI: 10.4088/JCP.10m06143gre  1
2012 Strauss GP, Gold JM, Cohen AS. Response to Gooding and Plfum, "The nature of diminished pleasure in individuals at risk for or affected by schizophrenia". Anticipatory and consummatory pleasure deficits across the schizophrenia spectrum Psychiatry Research. 198: 174-175. DOI: 10.1016/j.psychres.2012.06.040  1
2011 Morris SE, Holroyd CB, Mann-Wrobel MC, Gold JM. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Frontiers in Human Neuroscience. 5: 123. PMID 22065618 DOI: 10.3389/fnhum.2011.00123  1
2011 Strauss GP, Llerena K, Gold JM. Attentional disengagement from emotional stimuli in schizophrenia. Schizophrenia Research. 131: 219-23. PMID 21703824 DOI: 10.1016/j.schres.2011.06.001  1
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/a0021501  1
2011 Gold JM. Imaging emotion in schizophrenia: not finding feelings in all the right places. The American Journal of Psychiatry. 168: 237-9. PMID 21368303 DOI: 10.1176/appi.ajp.2010.10111653  1
2011 Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? Psychiatry Research. 187: 36-41. PMID 21295860 DOI: 10.1016/j.psychres.2011.01.012  1
2011 Kasanova Z, Waltz JA, Strauss GP, Frank MJ, Gold JM. Optimizing vs. matching: response strategy in a probabilistic learning task is associated with negative symptoms of schizophrenia. Schizophrenia Research. 127: 215-22. PMID 21239143 DOI: 10.1016/j.schres.2010.12.003  1
2011 Heerey EA, Matveeva TM, Gold JM. Imagining the future: degraded representations of future rewards and events in schizophrenia. Journal of Abnormal Psychology. 120: 483-9. PMID 21171727 DOI: 10.1037/a0021810  1
2011 Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry. 69: 424-31. PMID 21168124 DOI: 10.1016/j.biopsych.2010.10.015  1
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/j.schres.2010.11.008  1
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/j.biopsych.2010.09.052  1
2011 Waltz JA, Frank MJ, Wiecki TV, Gold JM. Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology. 25: 86-97. PMID 21090899 DOI: 10.1037/a0020882  1
2011 Wisner KM, ElvevÃ¥g B, Gold JM, Weinberger DR, Dickinson D. A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes. Schizophrenia Research. 126: 164-73. PMID 21030214 DOI: 10.1016/j.schres.2010.09.011  1
2011 Strauss GP, Robinson BM, Waltz JA, Frank MJ, Kasanova Z, Herbener ES, Gold JM. Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli. Schizophrenia Bulletin. 37: 1295-304. PMID 20484522 DOI: 10.1093/schbul/sbq047  1
2011 Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophrenia Bulletin. 37: 1157-67. PMID 20351040 DOI: 10.1093/schbul/sbq018  1
2011 Hahn B, Kappenman ES, Robinson BM, Fuller RL, Luck SJ, Gold JM. Iconic decay in schizophrenia. Schizophrenia Bulletin. 37: 950-7. PMID 20053864 DOI: 10.1093/schbul/sbp164  1
2011 Goldberg TE, David A, Gold JM. Neurocognitive Impairments in Schizophrenia: Their Character and Role in Symptom Formation Schizophrenia: Third Edition. 142-162. DOI: 10.1002/9781444327298.ch8  1
2010 Lamonica HM, Keefe RS, Harvey PD, Gold JM, Goldberg TE. Differential effects of emotional information on interference task performance across the life span. Frontiers in Aging Neuroscience. 2. PMID 20953250 DOI: 10.3389/fnagi.2010.00141  1
2010 Waltz JA, Schweitzer JB, Ross TJ, Kurup PK, Salmeron BJ, Rose EJ, Gold JM, Stein EA. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2427-39. PMID 20720534 DOI: 10.1038/npp.2010.126  1
2010 Weiner E, Conley RR, Ball MP, Feldman S, Gold JM, Kelly DL, Wonodi I, McMahon RP, Buchanan RW. Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2274-83. PMID 20664583 DOI: 10.1038/npp.2010.101  1
2010 Hahn B, Robinson BM, Kaiser ST, Harvey AN, Beck VM, Leonard CJ, Kappenman ES, Luck SJ, Gold JM. Failure of schizophrenia patients to overcome salient distractors during working memory encoding. Biological Psychiatry. 68: 603-9. PMID 20570242 DOI: 10.1016/j.biopsych.2010.04.014  1
2010 Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research. 121: 24-31. PMID 20542412 DOI: 10.1016/j.schres.2010.04.016  1
2010 Gold JM, Hahn B, Zhang WW, Robinson BM, Kappenman ES, Beck VM, Luck SJ. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Archives of General Psychiatry. 67: 570-7. PMID 20530006 DOI: 10.1001/archgenpsychiatry.2010.65  1
2010 Longenecker J, Genderson J, Dickinson D, Malley J, Elvevåg B, Weinberger DR, Gold J. Where have all the women gone?: participant gender in epidemiological and non-epidemiological research of schizophrenia. Schizophrenia Research. 119: 240-5. PMID 20399612 DOI: 10.1016/j.schres.2010.03.023  1
2010 Dickinson D, Tenhula W, Morris S, Brown C, Peer J, Spencer K, Li L, Gold JM, Bellack AS. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. The American Journal of Psychiatry. 167: 170-80. PMID 20008941 DOI: 10.1176/appi.ajp.2009.09020264  1
2009 Gold JM, Hahn B, Strauss GP, Waltz JA. Turning it upside down: areas of preserved cognitive function in schizophrenia. Neuropsychology Review. 19: 294-311. PMID 19452280 DOI: 10.1007/s11065-009-9098-x  1
2009 Shapiro DI, Marenco S, Spoor EH, Egan MF, Weinberger DR, Gold JM. The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophrenia Research. 112: 136-42. PMID 19410430 DOI: 10.1016/j.schres.2009.04.007  1
2009 Luck SJ, Kappenman ES, Fuller RL, Robinson B, Summerfelt A, Gold JM. Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential. Psychophysiology. 46: 776-86. PMID 19386044 DOI: 10.1111/j.1469-8986.2009.00817.x  1
2009 Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR. A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. The Journal of Clinical Psychiatry. 70: 518-25. PMID 19358788 DOI: 10.4088/JCP.08m04358  1
2009 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired visual working memory consolidation in schizophrenia. Neuropsychology. 23: 71-80. PMID 19210034 DOI: 10.1037/a0013854  1
2009 Waltz JA, Schweitzer JB, Gold JM, Kurup PK, Ross TJ, Salmeron BJ, Rose EJ, McClure SM, Stein EA. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1567-77. PMID 19052540 DOI: 10.1038/npp.2008.214  1
2008 Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, Meyer-Lindenberg A, Honea RA, Bigelow LB, Egan MF, Emsellem EM, Weinberger DR. Enuresis as a premorbid developmental marker of schizophrenia. Brain : a Journal of Neurology. 131: 2489-98. PMID 18669483 DOI: 10.1093/brain/awn167  1
2008 Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophrenia Research. 105: 78-85. PMID 18617370 DOI: 10.1016/j.schres.2008.05.027  1
2008 Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry. 64: 782-8. PMID 18597738 DOI: 10.1016/j.biopsych.2008.05.009  1
2008 Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophrenia Bulletin. 34: 835-47. PMID 18591195 DOI: 10.1093/schbul/sbn068  1
2008 Keefe RSE, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C, Hawkins K. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) Schizophrenia Research. 102: 108-115. PMID 18495435 DOI: 10.1016/j.schres.2008.03.024  1
2008 Luck SJ, Gold JM. The translation of cognitive paradigms for patient research. Schizophrenia Bulletin. 34: 629-44. PMID 18487226 DOI: 10.1093/schbul/sbn036  1
2008 Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biological Psychiatry. 64: 823-7. PMID 18472089 DOI: 10.1016/j.biopsych.2008.04.005  1
2008 Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. The American Journal of Psychiatry. 165: 1040-7. PMID 18381905 DOI: 10.1176/appi.ajp.2008.07071135  1
2008 Heerey EA, Bell-Warren KR, Gold JM. Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biological Psychiatry. 64: 62-9. PMID 18377874 DOI: 10.1016/j.biopsych.2008.02.015  1
2008 Luck SJ, Gold JM. The construct of attention in schizophrenia. Biological Psychiatry. 64: 34-9. PMID 18374901 DOI: 10.1016/j.biopsych.2008.02.014  1
2008 Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics. 49: 123-31. PMID 18354065 DOI: 10.1176/appi.psy.49.2.123  1
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/appi.ajp.2007.07010042  1
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/appi.ajp.2007.07010043  1
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/appi.ajp.2007.07010089  1
2008 Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP. Galantamine for the treatment of cognitive impairments in people with schizophrenia. The American Journal of Psychiatry. 165: 82-9. PMID 17986678 DOI: 10.1176/appi.ajp.2007.07050724  1
2008 Prentice KJ, Gold JM, Buchanan RW. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. 106: 81-7. PMID 17933496 DOI: 10.1016/j.schres.2007.07.015  1
2008 Morris SE, Heerey EA, Gold JM, Holroyd CB. Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophrenia Research. 99: 274-85. PMID 17889510 DOI: 10.1016/j.schres.2007.08.027  1
2008 Dickinson D, Gold JM. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin. 34: 423-34. PMID 17702991 DOI: 10.1093/schbul/sbm092  1
2008 Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry. 7: 32-33.  1
2007 Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. The American Journal of Psychiatry. 164: 1593-602. PMID 17898352 DOI: 10.1176/appi.ajp.2007.06081358  1
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/archpsyc.64.6.633  1
2007 Gold JM, Fuller RL, Robinson BM, Braun EL, Luck SJ. Impaired top-down control of visual search in schizophrenia. Schizophrenia Research. 94: 148-55. PMID 17544632 DOI: 10.1016/j.schres.2007.04.023  1
2007 Heerey EA, Gold JM. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology. 116: 268-78. PMID 17516760 DOI: 10.1037/0021-843X.116.2.268  1
2007 Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry. 64: 532-42. PMID 17485605 DOI: 10.1001/archpsyc.64.5.532  1
2007 Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophrenia Research. 93: 296-303. PMID 17482797 DOI: 10.1016/j.schres.2007.03.010  1
2007 Heerey EA, Robinson BM, McMahon RP, Gold JM. Delay discounting in schizophrenia. Cognitive Neuropsychiatry. 12: 213-21. PMID 17453902 DOI: 10.1080/13546800601005900  1
2007 Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biological Psychiatry. 62: 756-64. PMID 17300757 DOI: 10.1016/j.biopsych.2006.09.042  1
2007 Dickinson D, Bellack AS, Gold JM. Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin. 33: 1213-20. PMID 17164469 DOI: 10.1093/schbul/sbl067  1
2007 Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT, Buchanan RW. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophrenia Bulletin. 33: 1201-12. PMID 17159230 DOI: 10.1093/schbul/sbl066  1
2006 Gold JM, Fuller RL, Robinson BM, McMahon RP, Braun EL, Luck SJ. Intact attentional control of working memory encoding in schizophrenia. Journal of Abnormal Psychology. 115: 658-73. PMID 17100524 DOI: 10.1037/0021-843X.115.4.658  1
2006 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired control of visual attention in schizophrenia. Journal of Abnormal Psychology. 115: 266-75. PMID 16737391 DOI: 10.1037/0021-843X.115.2.266  1
2006 Shepard PD, Holcomb HH, Gold JM. Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophrenia Bulletin. 32: 417-21. PMID 16717257 DOI: 10.1093/schbul/sbj083  1
2006 Luck SJ, Fuller RL, Braun EL, Robinson B, Summerfelt A, Gold JM. The speed of visual attention in schizophrenia: electrophysiological and behavioral evidence. Schizophrenia Research. 85: 174-95. PMID 16713184 DOI: 10.1016/j.schres.2006.03.040  1
2006 Saperstein AM, Fuller RL, Avila MT, Adami H, McMahon RP, Thaker GK, Gold JM. Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction. Schizophrenia Bulletin. 32: 498-506. PMID 16687386 DOI: 10.1093/schbul/sbj072  1
2006 Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2033-46. PMID 16641947 DOI: 10.1038/sj.npp.1301072  1
2006 Velligan DI, Kern RS, Gold JM. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies Schizophrenia Bulletin. 32: 474-485. PMID 16641424 DOI: 10.1093/schbul/sbj071  1
2006 Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophrenia Research. 85: 20-9. PMID 16616831 DOI: 10.1016/j.schres.2006.03.003  1
2006 Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research. 81: 1-15. PMID 16202565 DOI: 10.1016/j.schres.2005.07.038  1
2005 Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal Neuropsychology. 19: 778-786. PMID 16351353 DOI: 10.1037/0894-4105.19.6.778  1
2005 Fuller RL, Luck SJ, McMahon RP, Gold JM. Working memory consolidation is abnormally slow in schizophrenia. Journal of Abnormal Psychology. 114: 279-90. PMID 15869358 DOI: 10.1037/0021-843X.114.2.279  1
Show low-probability matches.